Navigation Links
L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
Date:11/5/2012

BARCELONA, November 5, 2012 /PRNewswire/ --

- Life Sciences Entrepreneurs S.L.U. anuncia la primera financiación del antiplaquetario nmc por inversores españoles y suizos -

Life Science Entrepreneurs S.L.U., una empresa dedicada al desarrollo incipiente de proyectos de gran riesgo y muy alto beneficio, anuncia hoy la primera inversión para el medicamento candidato antiplaquetario denominado NmC.

Algunos inversores privados de Barcelona, Ginebra y Basilea, todos activos en las aplicaciones médicas de ciencias de la vida, han financiado los ensayos necesarios para confirmar la seguridad y eficacia del medicamento cardiovascular NmC.

"NmC puede prevenir incidentes cardiovasculares gracias a su forma exclusiva de diluir la sangre de los pacientes en riesgo", ha declarado François Arcand, Presidente de Life Science  Entrepreneurs S.L.U.. "El medicamento interesa a los expertos del sector porque su novedoso mecanismo de acción podría distinguirlo de antitrombóticos como Plavix ®, el estándar actual, o el recientemente incorporado Eliquis ®".

Los derechos sobre la molécula se han obtenido de una universidad extranjera. A principios de 2013, Life Science Entrepreneurs S.L.U. recaudará 2 millones de euros de inversores españoles y extranjeros para llevar a cabo un conjunto reglamentario y completo de ensayos preclínicos.

Acerca de ...

Life Science Entrepreneurs S.L.U. desarrolla descubrimientos científicos hasta la realización de una prueba de concepto viable, cuando las tecnologías probadas son adquiridas por organizaciones especializadas y de gran poder económico.  Para obtener más información, consulte http://www.LifSciE.com

 

Català : http://www.lifscie.com/cat/en/enemce/
English : http://www.lifscie.com/en/enemce/
Français : http://www.lifscie.com/fr/enemce/



'/>"/>
SOURCE Life Science Entrepreneurs S.L.U.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
Breaking Medicine News(10 mins):